Fintel reports that on August 15, 2024, JP Morgan downgraded their outlook for bluebird bio (MUN:BLE) from Overweight to Neutral. As of December 21, 2023, the average one-year price target for ...
Fintel reports that on November 15, 2024, B of A Securities downgraded their outlook for bluebird bio (MUN:BLE) from Buy to Neutral. As of December 21, 2023, the average one-year price target for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results